Cargando…

Expression of Syk and MAP4 proteins in ovarian cancer

PURPOSE: We have previously reported on the prognostic importance of the calpain family of proteins in ovarian cancer, especially calpain-2. Spleen tyrosine kinase (Syk) phosphorylates a variety of cytoskeletal proteins with studies suggesting potential interactions between Syk and conventional calp...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Siwei, Deen, Suha, Storr, Sarah J., Yao, Anqi, Martin, Stewart G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6435630/
https://www.ncbi.nlm.nih.gov/pubmed/30737623
http://dx.doi.org/10.1007/s00432-019-02856-9
_version_ 1783406674714820608
author Zhang, Siwei
Deen, Suha
Storr, Sarah J.
Yao, Anqi
Martin, Stewart G.
author_facet Zhang, Siwei
Deen, Suha
Storr, Sarah J.
Yao, Anqi
Martin, Stewart G.
author_sort Zhang, Siwei
collection PubMed
description PURPOSE: We have previously reported on the prognostic importance of the calpain family of proteins in ovarian cancer, especially calpain-2. Spleen tyrosine kinase (Syk) phosphorylates a variety of cytoskeletal proteins with studies suggesting potential interactions between Syk and conventional calpains. Microtubule-associated protein 4 (MAP4) has been reported to be regulated by Syk. METHODS: The current study assessed Syk and MAP4 protein expression, by immunohistochemistry on a tissue microarray comprised of cores from primary ovarian carcinomas (n = 575), to evaluate associations with patient clinical outcomes and other clinicopathological factors and sought to determine whether there were any correlations between the expression of Syk, MAP4 and the calpain system. RESULTS: MAP4 expression was significantly associated with ovarian cancer histological subtype (P < 0.001), stage (P = 0.001), grade (P < 0.001) and residual tumour (P = 0.005). Despite this finding, we found no significant association existing between MAP4 expression and overall survival. Syk expression was also found significantly associated with histological subtype (P < 0.001). Syk seems to play a contradictory role with respect to tumour progression: low cytoplasmic Syk expression was significantly associated with low stage (P = 0.013), and low nuclear Syk expression with chemo-resistance in patients treated with taxane-containing therapy (P = 0.006). Interestingly, despite the lack of association in the whole cohort, high nuclear Syk expression was significantly associated with better overall survival in certain subgroups (P = 0.001). CONCLUSIONS: The current study indicates a lack of correlation between calpain-2 expression and Syk and MAP4. Syk, MAP4 and calpain-1 appeared to significantly correlate with each other in the whole cohort, with calpain-1 being more highly associated with MAP4 and Syk in mucinous carcinomas. Overall, the current results suggest that Syk, MAP4, and calpain-1 expression are correlated with each other and these proteins may be involved in early stages of tumour spread. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00432-019-02856-9) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6435630
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-64356302019-04-15 Expression of Syk and MAP4 proteins in ovarian cancer Zhang, Siwei Deen, Suha Storr, Sarah J. Yao, Anqi Martin, Stewart G. J Cancer Res Clin Oncol Original Article – Cancer Research PURPOSE: We have previously reported on the prognostic importance of the calpain family of proteins in ovarian cancer, especially calpain-2. Spleen tyrosine kinase (Syk) phosphorylates a variety of cytoskeletal proteins with studies suggesting potential interactions between Syk and conventional calpains. Microtubule-associated protein 4 (MAP4) has been reported to be regulated by Syk. METHODS: The current study assessed Syk and MAP4 protein expression, by immunohistochemistry on a tissue microarray comprised of cores from primary ovarian carcinomas (n = 575), to evaluate associations with patient clinical outcomes and other clinicopathological factors and sought to determine whether there were any correlations between the expression of Syk, MAP4 and the calpain system. RESULTS: MAP4 expression was significantly associated with ovarian cancer histological subtype (P < 0.001), stage (P = 0.001), grade (P < 0.001) and residual tumour (P = 0.005). Despite this finding, we found no significant association existing between MAP4 expression and overall survival. Syk expression was also found significantly associated with histological subtype (P < 0.001). Syk seems to play a contradictory role with respect to tumour progression: low cytoplasmic Syk expression was significantly associated with low stage (P = 0.013), and low nuclear Syk expression with chemo-resistance in patients treated with taxane-containing therapy (P = 0.006). Interestingly, despite the lack of association in the whole cohort, high nuclear Syk expression was significantly associated with better overall survival in certain subgroups (P = 0.001). CONCLUSIONS: The current study indicates a lack of correlation between calpain-2 expression and Syk and MAP4. Syk, MAP4 and calpain-1 appeared to significantly correlate with each other in the whole cohort, with calpain-1 being more highly associated with MAP4 and Syk in mucinous carcinomas. Overall, the current results suggest that Syk, MAP4, and calpain-1 expression are correlated with each other and these proteins may be involved in early stages of tumour spread. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00432-019-02856-9) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2019-02-08 2019 /pmc/articles/PMC6435630/ /pubmed/30737623 http://dx.doi.org/10.1007/s00432-019-02856-9 Text en © The Author(s) 2019 OpenAccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Article – Cancer Research
Zhang, Siwei
Deen, Suha
Storr, Sarah J.
Yao, Anqi
Martin, Stewart G.
Expression of Syk and MAP4 proteins in ovarian cancer
title Expression of Syk and MAP4 proteins in ovarian cancer
title_full Expression of Syk and MAP4 proteins in ovarian cancer
title_fullStr Expression of Syk and MAP4 proteins in ovarian cancer
title_full_unstemmed Expression of Syk and MAP4 proteins in ovarian cancer
title_short Expression of Syk and MAP4 proteins in ovarian cancer
title_sort expression of syk and map4 proteins in ovarian cancer
topic Original Article – Cancer Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6435630/
https://www.ncbi.nlm.nih.gov/pubmed/30737623
http://dx.doi.org/10.1007/s00432-019-02856-9
work_keys_str_mv AT zhangsiwei expressionofsykandmap4proteinsinovariancancer
AT deensuha expressionofsykandmap4proteinsinovariancancer
AT storrsarahj expressionofsykandmap4proteinsinovariancancer
AT yaoanqi expressionofsykandmap4proteinsinovariancancer
AT martinstewartg expressionofsykandmap4proteinsinovariancancer